Astera Labs, Inc. $ALAB Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 66.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,590 shares of the company’s stock after selling 31,130 shares during the quarter. SG Americas Securities LLC’s holdings in Astera Labs were worth $1,709,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of ALAB. Atreides Management LP raised its position in shares of Astera Labs by 2,496.6% during the fourth quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after purchasing an additional 1,549,144 shares during the period. Amundi boosted its position in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the period. BNP Paribas Financial Markets boosted its position in shares of Astera Labs by 577.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares during the period. Artisan Partners Limited Partnership purchased a new position in Astera Labs in the 4th quarter worth about $148,980,000. Finally, Goldman Sachs Group Inc. increased its stake in Astera Labs by 189.0% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock worth $218,419,000 after purchasing an additional 858,693 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. UBS Group lifted their target price on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a research report on Monday. JPMorgan Chase & Co. boosted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Barclays upped their price target on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Finally, Susquehanna raised their price objective on shares of Astera Labs from $155.00 to $230.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $265.75.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the completion of the sale, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This represents a 7.39% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the sale, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,981,441 shares of company stock worth $444,969,514. Company insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB opened at $406.42 on Friday. The company has a market capitalization of $69.66 billion, a price-to-earnings ratio of 274.61, a P/E/G ratio of 4.94 and a beta of 3.66. Astera Labs, Inc. has a fifty-two week low of $88.18 and a fifty-two week high of $499.48. The business’s 50-day moving average is $310.47 and its 200-day moving average is $204.14.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s revenue was up 93.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.